Tag: #AstraZeneca #Immunai #AItechnology #cancerresearch #biotechnology

Rianta Capital Invests In Biotech Beauty Brand

In an era where innovation shapes the beauty landscape, the UK-based biotech skincare brand, Reome, has captured attention with its successful first round of funding. Launched by former beauty editor Joanna Ellner in January 2023, Reome recently raised over £1.1 million ($1.4 million) led by Rianta Capital, the investment arm of New Look founder Tom […]

AstraZeneca Invests $18 Million in Immunai's AI Technology

In a significant move highlighting the growing intersection of artificial intelligence and biopharmaceuticals, AstraZeneca has committed $18 million to Immunai Inc., a pioneer in AI-driven immunology research. This investment marks a strategic effort by AstraZeneca to enhance the precision and efficiency of its cancer drug trials, leveraging cutting-edge technology to navigate the complexities of immune […]

Back To Top